CEO Ton Büchner said that "we thank Keith for his dedication and commitment to AkzoNobel over the past eight years. He has played a major role in the transformation of the company's portfolio, most notably in the exit of our Pharmaceutical business and, since becoming CFO in 2008, has made an outstanding contribution in driving financial discipline and functional excellence across the company. We will miss Keith's valuable and insightful input as well as his hard work, and I know that I speak on behalf of all my colleagues in wishing him well for the future."
TAPPI
http://www.tappi.org/